Elastic-free face masks can help some with allergies stay safe during the pandemic
UC fellow presents case study related to COVID-19 during national meeting
A University of Cincinnati immunologist is recommending that individuals with contact dermatitis choose facial masks made without elastic or rubber that allow them to stay safe in the midst of COVID-19 while avoiding possible allergic reactions.
Yashu Dhamija, MD, a first-year fellow in the UC Division of Immunology, Allergy, and Rheumatology, presented his findings in an abstract while discussing a medically challenging case at the virtual American College of Allergy, Asthma and Immunology (ACAAI) scientific meeting held Nov. 13-15.
Yashu Dhamija, MD. Photo/Colleen Kelley/UC Creative + Brand
“How do you help patients manage a condition that puts them at risk for something like COVID-19?” asked Dhamija, who sees patients at UC Health and Cincinnnati VA Medical Center. “We definitely want our patients to use masks and apply social distancing. That’s a must. But they can avoid elastic components and use face masks that use the knot tie method around the back of the head to keep the masks up.”
Dhamija treated a patient who had been diagnosed with contact dermatitis, a reaction to allergens that touch or have contact with the skin. It is different from allergies to things such as dog or cat dander because with contact dermatitis the body’s response is not immediate.
“What makes contact dermatitis tricky is that it can be delayed so you may expose your skin to something and a reaction may not occur until days later,” said Dhamija. “Intermittent reactions can be tricky because you don’t know what the patient is exposing themselves to and the allergen could be at work or home.”
Contact dermatitis can affect up to 6% of the U.S. population.
Kristin Schmidlin, MD
The case report Dhamija discussed before the ACAAI involved a patient who visited a hospital emergency room three times during the spring with complaints of a facial rash and eyelid swelling. The patient was sent home with prednisone and was seen one to two weeks later during a telemedicine appointment during which he reported the rash had been going on for two weeks.
Physicians realized the rash occurred where the elastic parts of his facial mask would rest, explains Kristin Schmidlin, MD, an assistant professor in the UC Division of Immunology, Allergy, and Rheumatology and co-author of the abstract at ACAAI.
Schmidlin said physicians reduced the amount of prednisone and advised use of topical triamcinolone, a steroid that helps reduce inflammation and is commonly used in treating mouth sores. She said the patient was also advised to use a cotton-based, dye-free mask without elastic.
The patient was able to find a cloth mask and reported improved symptoms a week later, said Schmidlin.
The Centers for Disease Control and Prevention offers some guidelines for making masks at home and that’s a starting point for individuals with contact dermatitis.
“Instead of using elastics in a facial mask, I would modify it and use cotton-based knot ties around the back of the head to hold the mask in place,” says Dhamija. “We also advise patients to call companies that make facial masks to find out what’s in the product if labeling does not contain enough details.”
Yashu Dhamija, MD, is a fellow at the University of Cincinnati College of Medicine. Photo/Colleen Kelley/UC Creative + Brand
“There are immune reactions to allergens that can be life-threatening but when it comes to contact dermatitis, it doesn't escalate that far. We can quickly identify the allergen and stop the offending agent. But, some cases can be severe,” said Dhamija. “Treatment usually means avoiding the agent or we can use a topical or oral steroid if needed. It depends on how severe the reaction is and how much of the body is affected. We also take into account how it is impacting the patient's life or ability to work, for example.”
“Patch testing is a tool we use to detect contact dermatitis,” said Dhamija. “It’s good to speak with your primary care doctor or ask for a referral to an allergist if you have concerns. Patch testing involves placing a compound we suspect is a problem to your skin. We have you return a few days later and we see if there is a reaction.
Dhamija said there is abundant literature documenting patients with contact dermatitis because of allergens such as elastic bands in FFP2 masks, N95 respirators, neoprene rubber masks and medical masks containing formaldehyde or rubber components using carbamates or thiurams.
Featured image at top of Yashu Dhamija, MD. Photo/Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.